RCT of Bumetanide in Hypokalaemic Periodic Paralysis (HypoPP) Using Abductor Digiti Minimi Compound Muscle Action Potential (CMAP) as an Objective Outcome Measure
Neuromuscular Disorders - United Kingdom
doi 10.1016/s0960-8966(18)30370-5
Full Text
Open PDFAbstract
Available in full text
Date
April 1, 2018
Authors
Publisher
Elsevier BV